We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 2,300

Punitive damages not available under section 8 of the PM (NOC) Regulations

  • Norton Rose Fulbright LLP
  • -
  • Canada
  • -
  • November 17 2014

The Supreme Court of Canada has refused Teva’s application for leave to appeal the decision of the Federal Court of Appeal which had upheld an order

Nova regulamentação para Parcerias de Desenvolvimento Produtivo - PDPs

  • Mattos Filho, Veiga Filho, Marrey Jr e Quiroga Advogados
  • -
  • Brazil
  • -
  • November 14 2014

Após alguns meses de discussão entre o setor público e privado, o Ministério da Saúde promulgou, em 12 de Novembro de 2014, a Portaria nº 2.531, que

New regulation for Productive Development Partnerships - PDPs

  • Mattos Filho, Veiga Filho, Marrey Jr e Quiroga Advogados
  • -
  • Brazil
  • -
  • November 14 2014

After some months of discussions between the public and the private sector, on November 12, 2014 the Ministry of Health enacted Ordinance No. 2,531

News bytes

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • November 13 2014

The U.S. Food and Drug Administration (FDA) makes available Guidance for Industry and staff titled "Molecular Diagnostic Instruments with Combined

Inventive step or not, that is the question

  • V.O. Patents & Trademarks
  • -
  • United Kingdom
  • -
  • November 13 2014

The question whether or not the subject matter of a claim is inventive, is routinely determined by the so-called "problem-and-solution approach"

Judgment in AGA case confirms the need for harmonisation

  • V.O. Patents & Trademarks
  • -
  • United Kingdom
  • -
  • November 12 2014

In the case of AGA Medical Corporation vs. Occlutech (UK) Limited, the British High Court of Justice declared AGA's patent to be null and void

Lundbeck receives further good news this month over the patent term for LEXAPRO

  • AJ Park
  • -
  • Australia
  • -
  • November 12 2014

We recently reported the Australian High Court decision of ALPHAPHARM PTY LTD v H LUNDBECK AS. The High Court concluded that Lundbeck's application

The High Court confirms extensions of time for patent term extensions

  • Shelston IP
  • -
  • Australia
  • -
  • November 12 2014

The High Court of Australia has confirmed by a three to two majority that extensions of time under s223(2) of the Patents Act and the associated

The Federal Court brings generic manufacturers a step closer to a large damages payment in relation to Escitalopram

  • Shelston IP
  • -
  • Australia
  • -
  • November 12 2014

The Federal Court of Australia has dismissed an appeal by Alphapharm and others against the Commissioner of Patents decision to allow a patent term

CETA update our previously reported “good news” is maintained

  • Baker & McKenzie
  • -
  • Canada, European Union
  • -
  • November 11 2014

On September 26, 2014, the Government of Canada released the consolidated text for the Canada EU Comprehensive Economic and Trade Agreement (CETA